Nov 2026
Novel 4-Anilinopyrimidine-N-Acylhydrazone derivatives as dual EGFRWT/VEGFR-2 tyrosine kinase inhibitors against non-small cell lung Cancer: Design, synthesis, biological evaluation, and computational studies.
Two new series of 4-Anilinopyrimidine-N-acylhydrazone derivatives (7a-k and 9a-e) were designed and synthesized as potent dual EGFRWT/VEGFR-2 tyrosine kinase inhibitors, showing potent cytotoxicity against A549 NSCLC cells and stable complex formation of 9e with both targets.
T. H. Ibrahim, Hanan H. Kadry, Khaled O. Mohamed et al.
· Bioorganic chemistry (Print) · 0 citations